| [1] |
Hardy T, Mann DA. Epigenetics in liver disease: from biology to therapeutics. Gut, 2016, 65:1895-1905.
|
| [2] |
Waddington CH. The epigenotype. 1942. Int J Epidemiol, 2012, 41:10-13.
|
| [3] |
Gurdon JB. The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. J Embryol Exp Morp hol,1962,10:622-640.
|
| [4] |
Villanueva A, Portela A, Sayols S, et al. DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma. Hepatology, 2015, 61:1945-1956
|
| [5] |
Hausser J, Zavolan M. Identification and consequences of miRNA-target interactions--beyond repression of gene expression. Nat Rev Genet, 2014, 15:599-612.
|
| [6] |
Page A, Paoli P, Moran Salvador E, et al. Hepatic stellate cell transdifferentiation involves genome-wide remodeling of the DNA methylation landscape. J Hepatol, 2016, 64:661 -673
|
| [7] |
Tian W, Xu H, Fang F, et al. Brahma-related gene 1 bridges epigenetic regulation of proinflammatory cytokine production to steatohepatitis in mice. Hepatology, 2013, 58:576-588.
|
| [8] |
Page A, Paoli PP, Hill SJ, et al. Alcohol directly stimulates epigenetic modifications in hepatic stellate cells. J Hepatol, 2015, 62:388-397.
|
| [9] |
Roderburg C, Urban GW, Bettermann K, et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology, 2011, 53:209-218.
|
| [10] |
Chen L, Charrier A, Zhou Y, et al. Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells. Hepatology, 2014, 59:1118-1129.
|
| [11] |
Zeybel M, Hardy T, Robinson SM, et al. Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease. Clin Epigenetics, 2015, 7:25.
|
| [12] |
Murphy SK, Yang H, Moylan CA, et al. Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease. Gastroenterology, 2013, 145:1076-1087.
|
| [13] |
Hardy T, Zeybel M, Day CP, et al. Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease. Gut, Published Online First: 21 Mar 2016.
|
| [14] |
Bricambert J, Miranda J, Benhamed F, et al. Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice. J Clin Invest, 2010, 120:4316-4331.
|
| [15] |
Bandiera S, Pfeffer S, Baumert TF, et al. miR-122-a key factor and therapeutic target in liver disease. J Hepatol, 2015, 62:448-457.
|
| [16] |
Chen W, Yan ZH, Wang YM, et al. Genome-wide microarray-based analysis of miRNAs expression in patients with acute-on-chronic liver failure. Hepatobiliary Pancreat Dis Int, 2014, 13: 32-39.
|
| [17] |
Zhang W, Chen J, Wu M, et al. PRMT5 restricts hepatitis B virus replication via epigenetic repression of cccDNA transcription and interference with pgRNA encapsidation. Hepatology, 2017, Feb 25.
|
